New York, New York, Sept. 03, 2024 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (the “Company”) today announced that it has entered into a non-binding letter of intent (“LOI”) for a business combination with Shanghai Maius Pharmaceutical Technology Co., LTD (“Shanghai Maius”). Founded in 2015, Shanghai Maius is a biopharmaceutical R&D company focusing on innovative formulations and targeted small-molecule chemical drugs. Its core products include small-molecule chemical ...